Health Secretary Robert F. Kennedy Jr. has announced more than $281 million in new federal funding to expand addiction treatment, mental health services, overdose prevention, and recovery programs nationwide. The money will be distributed through 15 grant programs administered by the Substance Abuse and Mental Health Services Administration (SAMHSA) as part of President Trump’s Great American Recovery Initiative.

The largest award, totaling $68.2 million, will expand access to medication-assisted treatment for opioid use disorder. Another $55.7 million will fund Project AWARE, which supports school-based mental health services, while $40.6 million will strengthen treatment programs for children and young adults affected by trauma. Additional funding includes $34.7 million to train first responders to administer opioid overdose reversal medications and $22 million for mental health awareness training.

The package also provides funding for integrated behavioral healthcare, suicide prevention, recovery support services, workforce development, and alternatives to opioid-based pain treatment. The announcement follows the administration’s recent move to classify 7-hydroxymitragynine (7-OH) and related substances as Schedule I drugs.

The administration is spreading the funding across the places where people first encounter addiction and mental illness, not just treatment centers. Schools will expand mental health services, children dealing with trauma will gain greater access to care, first responders will receive more overdose-reversal medication and training, and treatment providers will have additional resources to help people stay in recovery…

If those two companies reach public markets, a similar story to SpaceX's $1.75T IPO will likely play out: “company goes public after its biggest growth has already occurred at the private stage.”

But there's a private company with a valuation north of $1B that’s still preparing for its biggest growth opportunities. Meet EnergyX, a company backed by General Motors, POSCO, and Eni that's open to you right now.

Their patented lithium technology can recover up to 3X more than traditional methods, 500X faster. Lithium demand is projected to grow 5X by 2040, In total, EnergyX’s project portfolio spans nearly 150,000 acres with up to 15M+ tons of untapped lithium.*

Over 50,000 investors have already put in more than $180M. Become an early-stage EnergyX investor by the July 16 deadline.

The largest grant, $68.2 million, is dedicated to expanding medication-assisted treatment for opioid addiction, reflecting the administration's focus on getting more people into treatment before another overdose occurs.

Synthetic opioid deaths climbed to roughly 76,000 in 2023 before beginning to decline, highlighting how widespread the crisis became. Expanding treatment, recovery services, and mental health care through local providers could help more people receive care before addiction leads to another overdose, arrest, or family breakdown.

People struggling with addiction rarely need just one service. Someone recovering from opioid addiction may also need counseling, help finding housing, or support staying sober after leaving rehab. This funding reflects that reality by distributing funds across a wide range of recipients, from schools and recovery organizations to first responders, rather than concentrating it in a single grant.

The largest award directs $68.2 million toward medication-assisted treatment for opioid addiction, while another $55.7 million expands school-based mental health services and $40.6 million supports children and young adults dealing with trauma. This was done intentionally and strategically in order to reach individuals at very different points in their lives, specifically before addiction becomes a lifelong cycle.

Surviving an overdose is often only the beginning of recovery. What happens in the weeks and months afterward usually determines whether someone stays sober or falls back into addiction. But stronger local treatment networks and recovery programs give affected individuals a much better shot at staying on the right path instead of returning to the emergency room or entering treatment all over again.

*Disclaimer: Energy Exploration Technologies, Inc. (“we”, “us”, “our”, and “EnergyX” is conducting an offering of securities pursuant to Regulation A of the Securities Act of 1933, as amended. An offering statement covering this offering has been qualified by the U.S. Securities and Exchange Commission (the “SEC”). Neither this communication nor any of its content constitutes an offer to sell, solicitation of an offer to buy or a recommendation for any of our securities by our company or any third party. Offers and sales of the securities are being made solely by means of the qualified offering circular. Investing in our securities involves significant risks. Before investing, you should consult with your financial advisor, accountant, and/or attorney legal, and carefully review the qualified offering circular (including the “Risk Factors” section) and any offering circular supplements.

The most recent qualified offering circular is available at https://www.sec.gov/Archives/edgar/data/1830166/000149315226017123/form253g2.htm. The most recent qualified offering circular and any supplements can also be found on the SEC’s EDGAR filing database, available at www.sec.gov/edgar/search/. Prospective investors should note that neither the SEC nor any federal or state securities commission or regulatory authority has approved or recommended our securities or determined that our offering circular is truthful or complete. Any representation to the contrary is unlawful. We are not a broker-dealer or investment adviser registered under the Securities Exchange Act of 1934 or the Investment Advisers Act of 1940. No communication made by us or any of our affiliates, through this communication or any other medium, should be construed as a recommendation to purchase, sell, or hold any securities, or as investment, tax, financial, accounting, legal, regulatory, or compliance advice. Neither this communication nor any of its content constitutes an offer to sell, solicitation of an offer to buy or a recommendation for any of our securities by our company or any third party. The content presented here is provided for general information purposes only and is not intended to solicit the purchase of securities or to be used as investment, legal or tax advice. Statement Regarding Forward-Looking Statements The information presented herein may include forward-looking statements, estimates, or projections regarding our anticipated future performance. If present, these statements are subject to risks, uncertainties, and assumptions. In some cases, you can identify these statements by forward-looking words such as “may”, “might”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “future” or “continue”, the negative of these terms, and other comparable terminology. Such forward-looking statements are based on current plans, estimates and expectations and are made pursuant to the Private Securities Litigation Reform Act of 1995. These statements, estimates and projections, if any, are based upon various assumptions made concerning our anticipated results and industry trends, which may or may not occur. We are not making any representations as to the accuracy of any such forward-looking statements, estimates or projections. Our actual performance may be materially different from any such statements, estimates or projections. We are under no duty to update any of these forward-looking statements to conform them to actual results or revised expectations.